Congestive heart failure left ventricular assist devices

Congestive heart failure Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Congestive heart failure from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Clinical Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Cardiac MRI
Echocardiography
Exercise Stress Test
Myocardial Viability Studies
Cardiac Catheterization
Endomyocardial biopsy
Treatment
Invasive Hemodynamic Monitoring
Medical Therapy: Acute Pharmacotherapy Chronic Pharmacotherapy: Diuretics ACE Inhibitors Angiotensin receptor blockers Aldosterone Antagonists Beta Blockers Ca Channel Blockers Nitrates Hydralazine Positive Inotropics Anticoagulants Antiarrhythmic Drugs Nutritional Supplements Omega-3-Fatty Acid Hormonal Therapies Drugs to Avoid Drug Interactions Treatment of underlying causes Associated conditions
Exercise Training
Surgical Therapy: Biventricular Pacing or Cardiac Resynchronization Therapy (CRT) Implantation of Intracardiac Defibrillator Ultrafiltration Cardiac Surgery Left Ventricular Assist Devices (LVADs) Cardiac Transplantation
ACC/AHA Guideline Recommendations: Hospitalized Patients Patients With a Prior MI Sudden Cardiac Death Prevention Patients at high risk for developing heart failure (Stage A) Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B) Patients with current or prior symptoms of heart failure (Stage C) Patients with refractory end-stage heart failure (Stage D)
Implementation of Practice Guidelines
Congestive heart failure end-of-life considerations
Specific Groups: Special Populations Patients who have concomitant disorders Obstructive Sleep Apnea in the Patient with CHF
Congestive heart failure left ventricular assist devices On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Congestive heart failure left ventricular assist devices
CDC on Congestive heart failure left ventricular assist devices
Congestive heart failure left ventricular assist devices in the news
Blogs on Congestive heart failure left ventricular assist devices</small>
Directions to Hospitals Treating Congestive heart failure left ventricular assist devices
Risk calculators and risk factors for Congestive heart failure left ventricular assist devices

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Left ventricular assist devices (LVADs) are temporary implantable cardiac devices to sustain a patient (i.e. "bridge" the patient) until cardiac transplantation can be performed. The use of LVADs as a "destination" device (the final treatment) rather than as a bridge is investigational at present.